Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus.

Infection and Immunity
J I FlockT Schennings

Abstract

The adherence characteristics in vivo and virulence of two isogenic strains of Staphylococcus aureus differing in fibronectin binding were compared in a rat model of catheter-induced infective endocarditis. No differences were found between the two strains. The results strongly point to the multifactorial nature of bacterial adherence to damaged heart valves and suggest that other binding functions can compensate for the lack of fibronectin binding in S. aureus.

References

Dec 14, 1978·Nature·P Kuusela
Jun 1, 1990·Microbial Pathogenesis·T B BuxtonG K Best
Jul 1, 1987·Reviews of Infectious Diseases·R J Hamill
Dec 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·W M ScheldR A Calderone
Jul 1, 1982·Infection and Immunity·E HéraïefL R Freedman

❮ Previous
Next ❯

Citations

Apr 23, 2004·Molecular Microbiology·Ulrich Schwarz-LinekJennifer R Potts
Aug 11, 2010·FEMS Microbiology Reviews·Brian HendersonMark A Williams
Nov 30, 2000·Current Infectious Disease Reports·M R Yeaman, A S Bayer
Jun 25, 2003·Current Opinion in Infectious Diseases·Barbara E Menzies
Jan 12, 2001·Clinical Orthopaedics and Related Research·A JohanssonO Svensson
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·S K MazmanianO Schneewind
Aug 3, 1999·Matrix Biology : Journal of the International Society for Matrix Biology·D JohM Höök
Sep 17, 1999·Journal of Clinical Microbiology·M G AmmendoliaL Baldassarri
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
Jul 3, 2002·Infectious Disease Clinics of North America·Philippe MoreillonArnold S Bayer
Jan 19, 2000·The Journal of Laboratory and Clinical Medicine·P FrancoisP Vaudaux

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.